Given that EZH2 directly targeted Ink4a/Arf, a tumor suppressor locus that is frequently inactivated in human GBM (Brennan et al., 2013), it is possible that EZH2 in SVZ astrocytes increases their oncogenic potential. This evidence concerns the gene EZH2 and glioblastoma.